Blog: EU Commission sees potential in protein-based COVID-19 vaccines – Yahoo Finance

Puurs, April 23 (Reuters) – Th EU Commission may eventually expand its portfolio of COVID-19 jabs to protein-based vaccines, the EU executive’s President Ursula von der Leyen suggested on Friday.

“We will certainly add other potential vaccines, for example protein-based vaccines have also quite a potential,” von der Leyen said at a news briefing.

The vaccines currently being developed by Novavax and Sanofi/Glaxo-Smith-Kline are examples of protein-based vaccines. (Reporting by Francesco Guarascio, writing by Sabine Siebold; Editing by Toby Chopra)

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s